Table 3:

Female Participant Outcomes including Male Characteristics in the Model

Variable	Level	Estimate	95% CI	P-value
Study group	Intervention	−0.0065	(−0.0745, 0.0616)	0.8519
Age at enrollment (years)		0.0024	(−0.0014, 0.0062)	0.2101
Education	None	−0.0518	(−0.1179, 0.0144)	0.1253
	Some-completed primary	−0.0373	(−0.0914, 0.0167)	0.1761
Marital status	Single	−0.0012	(−0.1881, 0.1858)	0.9902
	Common law/live together	0.1085	(−0.1536, 0.3707)	0.4171
ART Regimen (enrollment)	DTG	−0.0678	(−0.1445, 0.0089)	0.0832
Depression score		−0.0039	(−0.0088, 0.001)	0.1160
HIV score (knowledge)		0.0017	(−0.0028, 0.0062)	0.4585
HIV score (stigma)		−0.0004	(−0.0021, 0.0014)	0.6907
Age at enrollment (years), male		0.0013	(−0.0015, 0.0041)	0.3495
Education, male	None	−0.0282	(−0.0981, 0.0417)	0.4297
	Some-completed primary	−0.0307	(−0.0682, 0.0067)	0.1079
Marital status, male	Single	0.0026	(−0.1835, 0.1888)	0.9781
	Common law/live together	−0.0572	(−0.3193, 0.2049)	0.6688
Employment, male	Agriculture/Domestic	−0.0413	(−0.0812, −0.0015)	0.0429
ART Regimen (enrollment), male	DTG	0.1572	(0.0822, 0.2322)	0.0000
Depression score, male		0.0018	(−0.0033, 0.0069)	0.4897
HIV score (knowledge), male		0.0002	(−0.0065, 0.0069)	0.9484
HIV score (stigma), male		0.0002	(−0.0016, 0.002)	0.8208

Reference levels: Study group (control); Education (some secondary or beyond); Marital status (married); ART regimen (other); Employment status (other).

ART = Antiretroviral therapy; DTG = Dolutegravir.